Literature DB >> 27553189

Cerebral vasomotor reactivity in neurodegenerative diseases.

Łukasz Smoliński1, Anna Członkowska2.   

Abstract

Small-caliber cerebral vessels change their diameters in response to alterations of key metabolite concentrations such as carbon dioxide or oxygen. This phenomenon, termed the cerebral vasomotor reactivity (CVMR), is the basis for blood flow regulation in the brain in accordance with its metabolic status. Typically, CVMR is determined as the amount of change in cerebral blood flow in response to a vasodilating stimulus, which can be measured by various neuroimaging methods or by transcranial Doppler. It has been shown that CVMR is impaired in cerebrovascular diseases, but there is also evidence of a similar dysfunction in neurodegenerative disorders. Here, we review studies that have investigated CVMR in the common neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Moreover, we discuss potential neurodegenerative mechanisms responsible for the impairment of CVMR.
Copyright © 2016 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebral vasomotor reactivity; Multiple sclerosis; Neurodegenerative disease; Parkinson's disease

Mesh:

Year:  2016        PMID: 27553189     DOI: 10.1016/j.pjnns.2016.07.011

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  8 in total

1.  Age-related impairment of cerebral blood flow response to KATP channel opener in Alzheimer's disease mice with presenilin-1 mutation.

Authors:  Dong Liu; Ismayil Ahmet; Brandon Griess; David Tweedie; Nigel H Greig; Mark P Mattson
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-17       Impact factor: 6.200

2.  Cerebrovascular reactivity is blunted in young adults with major depressive disorder: The influence of current depressive symptomology.

Authors:  Ashley M Darling; Rauchelle E Richey; John D Akins; Erika F H Saunders; R Matthew Brothers; Jody L Greaney
Journal:  J Affect Disord       Date:  2021-08-29       Impact factor: 4.839

3.  Effects of sevoflurane versus propofol on cerebrovascular reactivity to carbon dioxide during laparoscopic surgery.

Authors:  Chunyi Wang; Cheng Ni; Gang Li; Yan Li; Liyuan Tao; Nan Li; Jun Wang; Xiangyang Guo
Journal:  Ther Clin Risk Manag       Date:  2017-10-10       Impact factor: 2.423

4.  Impaired Cerebral Vasomotor Reactivity in Alzheimer's Disease.

Authors:  Fernando Gongora-Rivera; Adolfo Cordero-Perez; Alejandro Gonzalez-Aquines; Antonio Anaya-Escamilla; Eduardo Villarreal-Garza; Meztli Espinosa-Ortega; Mario C Salinas-Carmona; Xochilt Ortiz-Jimenez
Journal:  Int J Alzheimers Dis       Date:  2018-09-09

5.  Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease.

Authors:  Laura Pelizzari; Maria Marcella Laganà; Federica Rossetto; Niels Bergsland; Mirco Galli; Giuseppe Baselli; Mario Clerici; Raffaello Nemni; Francesca Baglio
Journal:  Ther Adv Neurol Disord       Date:  2019-03-21       Impact factor: 6.570

Review 6.  The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment.

Authors:  Michela Sforza; Edoardo Bianchini; Diletta Alivernini; Marco Salvetti; Francesco E Pontieri; Giuliano Sette
Journal:  J Neural Transm (Vienna)       Date:  2022-10-07       Impact factor: 3.850

7.  Confounding of Cerebral Blood Flow Velocity by Blood Pressure During Breath Holding or Hyperventilation in Transient Ischemic Attack or Stroke.

Authors:  Alastair J S Webb; Matteo Paolucci; Sara Mazzucco; Linxin Li; Peter M Rothwell
Journal:  Stroke       Date:  2019-12-30       Impact factor: 7.914

Review 8.  The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis.

Authors:  Federico Paolini Paoletti; Simone Simoni; Lucilla Parnetti; Lorenzo Gaetani
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.